Found: 76
Select item for more details and to access through your institution.
Clinical-grade N-(4-[<sup>18</sup>F]fluorobenzoyl)-interleukin-2 for PET imaging of activated T-cells in humans.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1186/s41181-019-0062-7
- By:
- Publication type:
- Article
Radiolabeled Monoclonal Antibody Against Colony-Stimulating Factor 1 Receptor Specifically Distributes to the Spleen and Liver in Immunocompetent Mice.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.786191
- By:
- Publication type:
- Article
Preclinical characterisation of 111In-DTPA-trastuzumab.
- Published in:
- British Journal of Pharmacology, 2004, v. 143, n. 1, p. 99, doi. 10.1038/sj.bjp.0705915
- By:
- Publication type:
- Article
The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease—A Systematic Literature Review.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 6, p. 1241, doi. 10.3390/pharmaceutics14061241
- By:
- Publication type:
- Article
Modelling Tools to Characterize Acetaminophen Pharmacokinetics in the Pregnant Population.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 8, p. 1302, doi. 10.3390/pharmaceutics13081302
- By:
- Publication type:
- Article
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 10, p. 1540, doi. 10.2967/jnumed.124.267636
- By:
- Publication type:
- Article
Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for <sup>89</sup>Zr-Trastuzumab.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1815, doi. 10.2967/jnumed.123.265621
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted <sup>227</sup>Th-Conjugate Therapy in Mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 11, p. 1715, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging 1 reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging 1 reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer <sup>18</sup>F BMS-986192.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.241364
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of T-cells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Molecular imaging of PD‐L1 expression and dynamics with the adnectin‐based PET tracer<sup> 18</sup>F‐ BMS‐986192.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.241364
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.24187
- By:
- Publication type:
- Article
Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer <sup>18</sup>F-BMS-986192.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.241364
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer <sup>18</sup>F-BMS-986192.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.241364
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer <sup>18</sup>F-BMS-986192.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.241364
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Molecular imaging of PD‐L1 expression and dynamics with the adnectin‐based PET tracer <sup>18</sup>F‐BMS‐986192.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.241364
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Molecular imaging of PD-L1 expression and 1 dynamics with the adnectin-based PET tracer 18F BMS-986192.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.241364
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Roadmap for the Development and cGMP Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.216556
- By:
- Publication type:
- Article
Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 418, doi. 10.2967/jnumed.118.216556
- By:
- Publication type:
- Article
Molecular Imaging in Cancer Drug Development.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 5, p. 726, doi. 10.2967/jnumed.116.188045
- By:
- Publication type:
- Article
Theranostics Using Antibodies and Antibody-Related Therapeutics.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, p. 83S, doi. 10.2967/jnumed.116.186940
- By:
- Publication type:
- Article
Human Epidermal Growth Factor Receptor 3–Specific Tumor Uptake and Biodistribution of <sup>89</sup>Zr-MSB0010853 Visualized by Real-Time and Noninvasive PET Imaging.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 8, p. 1210, doi. 10.2967/jnumed.116.181586
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 6, p. 905, doi. 10.2967/jnumed.116.183475
- By:
- Publication type:
- Article